D.A. DAVIDSON & CO. - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2018$215,000
-22.7%
8,417
-39.1%
0.00%
-33.3%
Q4 2017$278,000
+186.6%
13,829
+110.7%
0.01%
+200.0%
Q2 2017$97,000
-4.9%
6,563
+2.2%
0.00%0.0%
Q1 2017$102,000
+142.9%
6,419
+84.2%
0.00%
+100.0%
Q4 2016$42,000
-83.0%
3,485
-60.8%
0.00%
-83.3%
Q3 2016$247,000
-13.3%
8,885
+8.0%
0.01%
-25.0%
Q2 2016$285,000
+74.8%
8,225
+36.0%
0.01%
+60.0%
Q1 2016$163,000
-19.7%
6,047
+0.8%
0.01%
-28.6%
Q4 2015$203,000
+44.0%
5,999
+21.4%
0.01%
+40.0%
Q3 2015$141,000
-50.9%
4,940
-23.2%
0.01%
-44.4%
Q2 2015$287,0006,4310.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders